{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:22:59Z","timestamp":1791559379060,"version":"4.3.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,19]]},"DOI":"10.7759\/cureus.114787","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T12:49:00Z","timestamp":1787143740000},"source":"Crossref","is-referenced-by-count":1,"title":["Fatal Persistent Cavitary Mycobacterium avium Complex Pulmonary Disease in a Non-HIV Patient With Prior Malignancy"],"prefix":"10.7759","author":[{"given":"Lina","family":"Ataya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aceil","family":"Shamieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1125","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"71","author":"Daley CL","year":"2020","unstructured":"Daley CL, Iaccarino JM, Lange C, et al.. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Clin Infect Dis. 2020, 71:905-13. 10.1093\/cid\/ciaa1125","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201107-1203OC","article-title":"Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease","volume":"185","author":"Hayashi M","year":"2012","unstructured":"Hayashi M, Takayanagi N, Kanauchi T, Miyahara Y, Yanagisawa T, Sugita Y. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2012, 185:575-83. 10.1164\/rccm.201107-1203OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04577-14","article-title":"Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease","volume":"59","author":"Lee BY","year":"2015","unstructured":"Lee BY, Kim S, Hong Y, et al.. Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease. Antimicrob Agents Chemother. 2015, 59:2972-7. 10.1128\/AAC.04577-14","journal-title":"Antimicrob Agents Chemother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.12.016","article-title":"Treatment duration and disease recurrence following the successful treatment of patients with Mycobacterium avium complex lung disease","volume":"157","author":"Furuuchi K","year":"2020","unstructured":"Furuuchi K, Morimoto K, Kurashima A, et al.. Treatment duration and disease recurrence following the successful treatment of patients with Mycobacterium avium complex lung disease. Chest. 2020, 157:1442-5. 10.1016\/j.chest.2019.12.016","journal-title":"Chest"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008058","article-title":"Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular\/bronchiectatic Mycobacterium avium complex lung disease","volume":"5","author":"Gochi M","year":"2015","unstructured":"Gochi M, Takayanagi N, Kanauchi T, Ishiguro T, Yanagisawa T, Sugita Y. Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular\/bronchiectatic Mycobacterium avium complex lung disease. BMJ Open. 2015, 5:e008058. 10.1136\/bmjopen-2015-008058","journal-title":"BMJ Open"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051315","article-title":"Long-term treatment outcome of progressive Mycobacterium avium complex pulmonary disease","volume":"9","author":"Fukushima K","year":"2020","unstructured":"Fukushima K, Kitada S, Abe Y, et al.. Long-term treatment outcome of progressive Mycobacterium avium complex pulmonary disease. J Clin Med. 2020, 9:10.3390\/jcm9051315","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.36416\/1806-3756\/e20200520","article-title":"Effect of coexisting advanced extrapulmonary solid cancer on progression of Mycobacterium avium complex lung disease","volume":"47","author":"Inoue R","year":"2021","unstructured":"Inoue R, Watanabe K, Saigusa Y, et al.. Effect of coexisting advanced extrapulmonary solid cancer on progression of Mycobacterium avium complex lung disease. J Bras Pneumol. 2021, 47:e20200520. 10.36416\/1806-3756\/e20200520","journal-title":"J Bras Pneumol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2185\/jrm.2020-032","article-title":"Pulmonary mycobacterium avium complex disease complicated by cancer: an 11-year survey at a single-center","volume":"16","author":"Kamei R","year":"2021","unstructured":"Kamei R, Sawahata M, Yoshizumi N, et al.. Pulmonary mycobacterium avium complex disease complicated by cancer: an 11-year survey at a single-center. J Rural Med. 2021, 16:72-6. 10.2185\/jrm.2020-032","journal-title":"J Rural Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr4058","article-title":"MAC attack: clinical correlates of Mycobacterium avium complex infection among patients with and without cancer","volume":"12","author":"Gupta K","year":"2020","unstructured":"Gupta K, Feinstein MB, Goldman DA, Patail HS, Stover DE. MAC attack: clinical correlates of Mycobacterium avium complex infection among patients with and without cancer. J Clin Med Res. 2020, 12:142-9. 10.14740\/jocmr4058","journal-title":"J Clin Med Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2021.2470","article-title":"Mycobacterium avium complex lung disease in a patient treated with an immune checkpoint inhibitor: a case report","volume":"16","author":"Yamaba Y","year":"2022","unstructured":"Yamaba Y, Takakuwa O, Tomita Y, et al.. Mycobacterium avium complex lung disease in a patient treated with an immune checkpoint inhibitor: a case report. Mol Clin Oncol. 2022, 16:37. 10.3892\/mco.2021.2470","journal-title":"Mol Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/509580-fatal-persistent-cavitary-mycobacterium-avium-complex-pulmonary-disease-in-a-non-hiv-patient-with-prior-malignancy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T12:49:01Z","timestamp":1787143741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/509580-fatal-persistent-cavitary-mycobacterium-avium-complex-pulmonary-disease-in-a-non-hiv-patient-with-prior-malignancy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.114787","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,19]]}}}